Online Biomedical Resources for Malaria-Related Red Cell Disorders

Human Mutation

Volumn 34, Issue 7, 2013, Pages 937-944

  Piel, Frédéric B ^a   Howes, Rosalind E ^a   Nyangiri, Oscar A ^b   Moyes, Catherine L ^a   Williams, Thomas N ^b,c   Weatherall, David J ^d   Hay, Simon I ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b KENYA MEDICAL RESEARCH INSTITUTE   (Kenya)

^c UNIVERSITY OF OXFORD   (United Kingdom)

^d UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Database; G6PD; HbC; HbE; HbS; Malaria; Thalassemia

Indexed keywords

HEMOGLOBIN C; HEMOGLOBIN S;

ARTICLE; BLOOD GROUP DUFFY SYSTEM; DISEASE ASSOCIATION; ERYTHROCYTE DISORDER; GENETIC DATABASE; GENETIC VARIABILITY; GLUCOSE 6 PHOSPHATE DEHYDROGENASE DEFICIENCY; HEMOGLOBIN C DISEASE; HEMOGLOBIN SC DISEASE; HUMAN; MALARIA; NONHUMAN; PRIORITY JOURNAL;

DATABASES, FACTUAL; DATABASES, GENETIC; HEMOGLOBINOPATHIES; HUMANS; INTERNET; MALARIA;

EID: 84879418620     PISSN: 10597794     EISSN: 10981004     Source Type: Journal    
DOI: 10.1002/humu.22330     Document Type: Article

References (78)

1. Akinyanju O. 2010. The National Burden of Sickle Cell Disorder and the Way Forward. Sickle Cell Foundation Nigeria. Available at: http://www.sicklecellfoundation.com/Nat%20Burden%20SCD.pdf. Accessed 15 November 2012.
2. Al-Jader LN, Harper PS, Krawczak M, Palmer SR. 2001. The frequency of inherited disorders database: prevalence of Huntington disease. Community Genet 4:148-157.
3. Angastiniotis MA, Hadjiminas MG. 1981. Prevention of thalassaemia in Cyprus. Lancet 317:369-371.
4. Balgir RS. 2000. The burden of haemoglobinopathies in India and the challenges ahead. Curr Sci 79:1536-1547.
5. Bardakdjian-Michau J, Bahuau M, Hurtrel D, Godart C, Riou J, Mathis M, Goossens M. 2009. Neonatal screening for sickle cell disease in France. J Clin Pathol 62:31-33.
6. Cappellini MD, Fiorelli G. 2008. Glucose-6-phosphate dehydrogenase deficiency. Lancet 371:64-74.
7. Carter R. 2003. Speculations on the origins of Plasmodium vivax malaria. Trends Parasitol 19:214-219.
8. Carter R, Mendis KN. 2002. Evolutionary and historical aspects of the burden of malaria. Clin Microbiol Rev 15:564-594.
9. Cavalli-Sforza LL, Menozzi P, Piazza A. 1994. The history and geography of human genes. Princeton, NJ: Princeton University Press.
10. Cerda LJ, Valdivia CG. 2007. John Snow, the cholera epidemic and the foundation of modern epidemiology. Rev Chilena Infectol 24:331-334.
11. Cheung KH, Osier MV, Kidd JR, Pakstis AJ, Miller PL, Kidd KK. 2000. ALFRED: an allele frequency database for diverse populations and DNA polymorphisms. Nucleic Acids Res 28:361-363.
12. Colah R, Gorakshakar A, Nadkarni A. 2010. Global burden, distribution and prevention of beta-thalassemias and hemoglobin E disorders. Expert Rev Hematol 3:103-117.
13. Das P, Horton R. 2010. Malaria elimination: worthy, challenging, and just possible. Lancet 376:1515-1517.
14. Delaunay J. 2007. The molecular basis of hereditary red cell membrane disorders. Blood Rev 21:1-20.
15. Diggle PJ, Ribeiro Jr PJ. 2007. Model-Based Geostatistics. Springer, New York, USA.
16. Flint J, Harding RM, Boyce AJ, Clegg JB. 1998. The population genetics of the haemoglobinopathies. Bailliere Clin Haem 11:1-51.
17. Galperin MY, Fernandez-Suarez XM. 2012. The 2012 nucleic acids research database issue and the online molecular biology database collection. Nucleic Acids Res 40:D1-D8.
18. Gething PW, Elyazar IRF, Moyes CL, Smith DL, Battle KE, Guerra CA, Patil AP, Tatem AJ, Howes RE, Myers MF, George DB, Horby P, et al. 2012. A long neglected world malaria map: Plasmodium vivax endemicity in 2010. PLoS Negl Trop Dis 6:e1814.
19. Giardine B, Borg J, Higgs DR, Peterson KR, Philipsen S, Maglott D, Singleton BK, Anstee DJ, Basak AN, Clark B, Costa FC, Faustino P, et al. 2011. Systematic documentation and analysis of human genetic variation in hemoglobinopathies using the microattribution approach. Nat Genet 43:295-301.
20. Giardine B, van Baal S, Kaimakis P, Riemer C, Miller W, Samara M, Kollia P, Anagnou NP, Chui DH, Wajcman H, Hardison RC, Patrinos GP. 2007. HbVar database of human hemoglobin variants and thalassemia mutations: 2007 update. Hum Mutat 28:206.
21. Grosse SD, Odame I, Atrash HK, Amendah DD, Piel FB, Williams TN. 2011. Sickle cell disease in Africa: a neglected cause of early childhood mortality. Am J Prev Med 41:S398-S405.
22. Guerra CA, Howes RE, Patil AP, Gething PW, Van Boeckel TP, Temperley WH, Kabaria CW, Tatem AJ, Manh BH, Elyazar IRF, Baird JK, Snow RW, et al. 2010. The international limits and population at risk of Plasmodium vivax transmission in 2009. PLoS Negl Trop Dis 4:e774.
23. Hardison RC, Chui DH, Giardine B, Riemer C, Patrinos GP, Anagnou N, Miller W, Wajcman H. 2002. HbVar: A relational database of human hemoglobin variants and thalassemia mutations at the globin gene server. Hum Mutat 19:225-233.
24. Hassell KL. 2010. Population estimates of sickle cell disease in the U.S. Am J Prev Med 38:S512-S521.
25. Hedrick PW. 2011. Population genetics of malaria resistance in humans. Heredity 107:283-304.
26. Hill AV. 1987. Haemoglobinopathies and malaria: new approaches to an old hypothesis. Parasitol Today 3:83-85.
27. Howes RE, Battle KE, Satyagraha AW, Baird JK, Hay SI. 2013. G6PD deficiency: global distribution, genetic variants and primaquine therapy. Adv Parasitol 81:133-201.
28. Howes RE, Patil AP, Piel FB, Nyangiri OA, Kabaria CW, Gething PW, Zimmerman PA, Barnadas C, Beall CM, Gebremedhin A, Menard D, Williams TN, et al. 2011. The global distribution of the Duffy blood group. Nat Commun 2:266.
29. Howes RE, Piel FB, Patil AP, Nyangiri OA, Gething PW, Dewi M, Hogg MM, Battle KE, Padilla CD, Baird JK, Hay SI. 2012. G6PD deficiency prevalence and estimates of affected populations in malaria endemic countries: a geostatistical model-based map. PLoS Med 9:e1001339.
30. Ingram VM. 1956. A specific chemical difference between the globins of normal human and sickle-cell anaemia haemoglobin. Nature 178:792-794.
31. Kasehagen LJ, Mueller I, Kiniboro B, Bockarie MJ, Reeder JC, Kazura JW, Kastens W, McNamara DT, King CH, Whalen CC, Zimmerman PA. 2007. Reduced Plasmodium vivax erythrocyte infection in PNG Duffy-negative heterozygotes. PLoS ONE 2:e336.
32. Kidson C, Lamont G, Saul A, Nurse GT. 1981. Ovalocytic erythrocytes from Melanesians are resistant to invasion by malaria parasites in culture. Proc Natl Acad Sci USA 78:5829-5832.
33. Kwiatkowski DP. 2005. How malaria has affected the human genome and what human genetics can teach us about malaria. Am J Hum Genet 77:171-192.
34. Liu S-C, Zhai S, Palek J, Golan DE, Amato D, Hassan K, Nurse GT, Babona D, Coetzer T, Jarolim P, Zaik M, Borwein S. 1990. Molecular defect of the band 3 protein in Southeast Asian Ovalocytosis. N Engl J Med 323:1530-1538.
35. Livingstone FB. 1973. Data on the Abnormal Hemoglobins and Glucose-6-Phosphate Dehydrogenase Deficiency in Human Populations, 1967-1973. Ann Arbor: Museum of Anthropology, University of Michigan.
36. Livingstone FB. 1984. The Duffy blood groups, vivax malaria, and malaria selection in human populations: a review. Hum Biol 56:413-425.
37. Livingstone FB. 1985. Frequencies of hemoglobin variants: thalassemia, the glucose-6-phosphate dehydrogenase deficiency, G6PD variants, and ovalocytosis in human populations. New York/Oxford: OUP.
38. Livingstone FB, Marks J. 2009. Abnormal Hemoglobins in Human Populations: Aldine Transaction, New Jersey, USA.
39. Luzzatto L, Notaro R. 2001. Protecting against bad air. Science 293:442-443.
40. Makani J, Williams TN, Marsh K. 2007. Sickle cell disease in Africa: burden and research priorities. Ann Trop Med Parasitol 101:3-14.
41. Marks J. 1989. Molecular micro- and macroevolution in the primate alpha-globin gene family. Am J Hum Biol 1:555-566.
42. Mason PJ, Bautista JM, Gilsanz F. 2007. G6PD deficiency: the genotype-phenotype association. Blood Rev 21:267-283.
43. Menard D, Barnadas C, Bouchier C, Henry-Halldin C, Gray LR, Ratsimbasoa A, Thonier V, Carod JF, Domarle O, Colin Y, Bertrand O, Picot J, et al. 2010. Plasmodium vivax clinical malaria is commonly observed in Duffy-negative Malagasy people. Proc Natl Acad Sci USA 107:5967-5971.
44. Mercereau-Puijalon O, Menard D. 2010. Plasmodium vivax and the Duffy antigen: a paradigm revisited. Transfus Clin Biol: J de la Societe Francaise de Transfusion Sanguine 17:176-183.
45. Miller LH, Mason SJ, Clyde DF, McGinniss MH. 1976. The resistance factor to Plasmodium vivax in blacks. The Duffy-blood-group genotype, FyFy. N Engl J Med 295:302-304.
46. Modell B, Darlison M. 2008. Global epidemiology of haemoglobin disorders and derived service indicators. Bull World Health Organ 86:480-487.
47. Murray CJ, Ezzati M, Flaxman AD, Lim S, Lozano R, Michaud C, Naghavi M, Salomon JA, Shibuya K, Vos T, Lopez AD. 2012. GBD 2010: a multi-investigator collaboration for global comparative descriptive epidemiology. Lancet 380:2055-2058.
48. National Newborn Screening and Genetics Resource Center (NNSGRC). 2011. National Newborn Screening Status Report. Austin, TX, USA.
49. Ohene-Frempong K, Oduro J, Tetteh H, Nkrumah F. 2008. Screening newborns for sickle cell disease in Ghana. Pediatrics 121:S120-S121.
50. Olivieri NF, Muraca GM, O'Donnell A, Premawardhena A, Fisher C, Weatherall DJ. 2008. Studies in haemoglobin E beta-thalassaemia. Br J Haematol 141:388-397.
51. Patil AP, Gething PW, Piel FB, Hay SI. 2011. Bayesian geostatistics in health cartography: the perspective of malaria. Trends Parasitol 27:246-253.
52. Patil AP, Huard D, Fonnesbeck CJ. 2010. PyMC: Bayesian stochastic modelling in Python. J Statist Softw 35:1-81.
53. Patrinos GP, Giardine B, Riemer C, Miller W, Chui DH, Anagnou NP, Wajcman H, Hardison RC. 2004. Improvements in the HbVar database of human hemoglobin variants and thalassemia mutations for population and sequence variation studies. Nucleic Acids Res 32:D537-D541.
54. Pauling L, Itano HA, Singer SJ, Wells IC. 1949. Sickle cell anemia a molecular disease. Science 110:543-548.
55. Piel FB, Howes RE, Patil AP, Nyangiri OA, Gething PW, Bhatt S, Williams TN, Weatherall DJ, Hay SI. 2013a. The distribution of haemoglobin C and its prevalence in newborns in Africa. Sci Rep 3:1671.
56. Piel FB, Patil AP, Howes RE, Nyangiri OA, Gething PW, Dewi M, Temperley WH, Williams TN, Weatherall DJ, Hay SI. 2013b. Global epidemiology of sickle haemoglobin in neonates: a contemporary geostatistical model-based map and population estimates. Lancet 381:142-151.
57. Piel FB, Patil AP, Howes RE, Nyangiri OA, Gething PW, Williams TN, Weatherall DJ, Hay SI. 2010. Global distribution of the sickle cell gene and geographical confirmation of the malaria hypothesis. Nat Commun 1:104.
58. Powars DR, Hiti A, Ramicone E, Johnson C, Chan L. 2002. Outcome in hemoglobin SC disease: A four-decade observational study of clinical, hematologic, and genetic factors. Am J Hematol 70:206-215.
59. Rosanas-Urgell A, Lin E, Manning L, Rarau P, Laman M, Senn N, Grimberg BT, Tavul L, Stanisic DI, Robinson LJ, Aponte JJ, Dabod E, et al. 2012. Reduced risk of Plasmodium vivax malaria in Papua New Guinean children with Southeast Asian Ovalocytosis in two cohorts and a case-control study. PLoS Med 9:e1001305.
60. Ruwende C, Khoo SC, Snow RW, Yates SN, Kwiatkowski D, Gupta S, Warn P, Allsopp CE, Gilbert SC, Peschu N, Newbold CI, Greenwood BM, et al. 1995. Natural selection of hemi- and heterozygotes for G6PD deficiency in Africa by resistance to severe malaria. Nature 376:246-249.
61. Sellami MH, Kaabi H, Midouni B, Dridi A, Mojaat N, Boukef MK, Hmida S. 2008. Duffy blood group system genotyping in an urban Tunisian population. An Hum Biol 35:406-415.
62. Serjeant GR, Serjeant BE. 2001. Sickle cell disease. Oxford, UK: Oxford University Press.
63. Streetly A, Latinovic R, Hall K, Henthorn J. 2009. Implementation of universal newborn bloodspot screening for sickle cell disease and other clinically significant haemoglobinopathies in England: screening results for 2005-7. J Clin Path 62:26-30.
64. United Nations. 2008. Recognition of Sickle-Cell Anaemia as a Public Health Problem. Resolution adopted by the General Assembly.
65. van Baal S, Kaimakis P, Phommarinh M, Koumbi D, Cuppens H, Riccardino F, Macek M, Jr., Scriver CR, Patrinos GP. 2007. FINDbase: a relational database recording frequencies of genetic defects leading to inherited disorders worldwide. Nucleic Acids Res 35:D690-D695.
66. Vichinsky E. 2007. Hemoglobin E syndromes. ASH Education Program Book 2007:79-83.
67. Weatherall D, Akinyanju O, Fucharoen S, Olivieri N, Musgrove P. 2006. Inherited disorders of hemoglobin. Disease Control Priorities in Developing Countries (2nd Edition). New York: Oxford University Press. p 663-680.
68. Weatherall DJ. 2001. Phenotype-genotype relationships in monogenic disease: lessons from the thalassaemias. Nat Rev Genet 2:245-55.
69. Weatherall DJ. 2010. The inherited diseases of hemoglobin are an emerging global health burden. Blood 115:4331-4336.
70. Weatherall DJ. 2011. The challenge of haemoglobinopathies in resource-poor countries. Br J Haematol 154:736-744.
71. Weatherall DJ, Clegg JB. 2001. The Thalassaemia Syndromes. Oxford/Malden, MA: Blackwell Science.
72. Whitelaw TH. 1923. Modern epidemiology. Can Med Assoc J 13:428-431.
73. Williams TN. 2006. Human red blood cell polymorphisms and malaria. Curr Opin Microbiol 9:388-394.
74. Williams TN, Mwangi TW, Roberts DJ, Alexander ND, Weatherall DJ, Wambua S, Kortok M, Snow RW, Marsh K. 2005. An immune basis for malaria protection by the sickle cell trait. PLoS Med 2:e128.
75. World Health Organization. 2006. Fifty-ninth World Health Assembly, Resolutions and Decisions, Annexes (WHA59/2006/REC/1). Geneva.
76. Wurtz N, Mint Lekweiry K, Bogreau H, Pradines B, Rogier C, Ould Mohamed Salem Boukhary A, Hafid JE, Ould Ahmedou Salem MS, Trape JF, Basco LK, Briolant S. 2011. Vivax malaria in Mauritania includes infection of a Duffy-negative individual. Malar J 10:336.
77. Zhao X, Li Z, Zhang X. 2010. G6PD-MutDB: a mutation and phenotype database of glucose-6-phosphate (G6PD) deficiency. J Bioinformatics Comput Biol 8 Suppl 1:101-109.
78. Zimmerman PA, Ferreira MU, Howes RE, Mercereau-Puijalon O. 2013. Red blood cell polymorphism and susceptibility to Plasmodium vivax. Adv Parasitol 81:27-76.